Overview

This trial is active, not recruiting.

Condition head and neck cancers
Sponsor Memorial Sloan Kettering Cancer Center
Collaborator American Cancer Society, Inc.
Start date February 2004
End date December 2016
Trial size 1307 participants
Trial identifier NCT00580203, 04-017

Summary

This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Arm
Patients with head and neck cancers

Primary Outcomes

Measure
Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future.
time frame: 36 months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes. - Patients will be entered onto this protocol without preference for any racial or ethnic group. - Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy. - The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded. Exclusion Criteria: - Patients not giving informed consent will be excluded.

Additional Information

Official title Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers
Principal investigator Bhuvanesh Singh, MD
Description This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center.